CD274 and neoplasm: Widely used biomarkers for response, including PD-L1 expression and tumor mutational burden, achieve an area under the receiver operatic characteristic curve (AUC-ROC) between 0.51 and 0.74 [11,13], suggesting that key aspects of the biology underlying response to ICI remain enigmatic.